4.5 Article

Quantitative protein expression profiling of 14-3-3 isoforms in human renal carcinoma shows 14-3-3 epsilon is involved in limitedly increasing renal cell proliferation

Journal

ELECTROPHORESIS
Volume 30, Issue 23, Pages 4152-4162

Publisher

WILEY
DOI: 10.1002/elps.200900249

Keywords

14-3-3 isoforms; Leu-d(3); Quantitative proteomics; Renal cell carcinoma; SILAC

Funding

  1. National Key Basic Research Program of China [2004CB518800]
  2. National Natural Sciences Foundation of China [20505006]
  3. Sichuan Province Funded Project [2008JY0033]

Ask authors/readers for more resources

14-3-3 proteins regulate many cellular processes that are implicated in cancer development, and the seven 14-3-3 isoforms have different expression level and isoform-specific roles in different tumors. However, the biological functions of 14-3-3 proteins and their correlations with renal carcinoma have not been investigated so far. In our study, the expression profiles and functional characterization of 14-3-3 proteins were discovered by a sensitive stable isotope labeling with amino acids in cell culture based quantitative proteomics analysis in human renal carcinoma tissues. We found that 14-3-3 epsilon was up-regulated with 1.44-fold changes in renal cancerous tissues compared with that in counterpart kidney tissues, and 1.4-3-3 sigma was almost not detected in both tissues due to its DNA highly methylated in our previous reports. The other five isoforms almost have similar expression level in two states of renal tissues. The following RT-PCR, Western blot and immunohistochemistry analysis for specific 14-3-3 isoform. expression were all consistent with the quantitative proteomic data. Furthermore, the overexpression of 14-3-3 epsilon in vitro can limitedly prompt the abnormal growth of renal tumor cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available